INTERNATIONAL PATENT: INSTITUT BAULIEU FONDS DE DOTATION FILES APPLICATION FOR "NEW PEPTIDE PP1 OF FKBP52 AND DERIVATIVES AND USE OF THE THERAPEUTIC PEPTIDES THAT INHIBIT PATHOLOGICAL TAU AGGREGATION FOR THERAPEUTIC PURPOSES"

GENEVA, Nov. 3 -- INSTITUT BAULIEU FONDS DE DOTATION (34 avenue Bosquet75007 PARIS) filed a patent application (PCT/IB2025/000161) for "NEW PEPTIDE PP1 OF FKBP52 AND DERIVATIVES AND USE OF THE THERAPEUTIC PEPTIDES THAT INHIBIT PATHOLOGICAL TAU AGGREGATION FOR THERAPEUTIC PURPOSES" on Apr 18, 2025. With publication no. WO/2025/224502, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BAULIEU, Etienne-Emile (INSERM U1195Institut Professeur Baulieu Hopital BicetrePorte 47 Batiment Gregory Pincus, 2eme etage, secteur marron80 r...